
5-Amino-1-methylquinolinium (5-Amino-1MQ) is a small molecule inhibitor of nicotinamide N-methyltransferase (NNMT). Researched for its effects on NAD+ metabolism, fat cell differentiation, and metabolic regulation in adipose tissue.
mg/vial
Research Purposes Only. Not for human or veterinary use.
Research & Science
5-Amino-1MQ is a small-molecule peptide analog investigated for its ability to influence metabolic pathways through the inhibition of nicotinamide N-methyltransferase (NNMT). NNMT plays a regulatory role in cellular energy balance, and its overactivity has been associated with impaired metabolic efficiency. This compound has become a growing area of interest in research focused on mitochondrial function, NAD⁺ preservation, and metabolic regulation.
Early studies exploring 5-Amino-1MQ have indicated several potential biological effects, including:
Unlike some broad-acting metabolic modulators, 5-Amino-1MQ has been studied for its selectivity, targeting NNMT without significant interaction with unrelated enzymes in experimental models.
In preclinical settings, 5-Amino-1MQ has shown potential for:
These findings have contributed to its emergence as a valuable molecule in metabolic research.
Ongoing investigations are examining the compound's potential relevance in:
Its connection to mitochondrial and metabolic pathways has positioned 5-Amino-1MQ as a promising candidate for advanced biochemical research.
5-Amino-1MQ is provided strictly for laboratory research purposes. It is not approved for human or animal administration and must not be used for therapeutic, diagnostic, or clinical applications. Use is limited to qualified research professionals in controlled environments.